We are live on ! Find out more
PP

Pacifica Partners Portfolio holdings

AUM $332M
1-Year Est. Return 59.28%
This Fund
S&P 500
This Quarter Est. Return
+6.15%
1 Year Est. Return
+59.28%
3 Year Est. Return
+122.71%
5 Year Est. Return
+144.58%
10 Year Est. Return
AUM
$301M
AUM Growth
+$76.1M
Cap. Flow
+$69.8M
Cap. Flow %
23.18%
Top 10 Hldgs %
34.04%
Holding
488
New
53
Increased
41
Reduced
91
Closed
38

Top Sells

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$4.78M
2
LRCX icon
Lam Research
LRCX
+$1.21M
3
O icon
Realty Income
O
+$762K
4
WMT icon
Walmart Inc
WMT
+$744K
5
CL icon
Colgate-Palmolive
CL
+$678K

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Financials 19.06%
3 Energy 16.01%
4 Communication Services 7.39%
5 Consumer Staples 4.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOCU
351
DocuSign
DOCU
$9.63B
$5.69K ﹤0.01%
120
-45
-27% -$2.3K
NVO
352
Novo Nordisk
NVO
$216B
$5.62K ﹤0.01%
153
CCI icon
353
Crown Castle
CCI
$32.7B
$5.61K ﹤0.01%
69
CTSH icon
354
Cognizant
CTSH
$21.5B
$5.21K ﹤0.01%
85
LHX icon
355
L3Harris
LHX
$55.9B
$5.18K ﹤0.01%
15
MRVL icon
356
Marvell Technology
MRVL
$174B
$4.85K ﹤0.01%
49
OXY.WS icon
357
Occidental Petroleum Corp Warrants
OXY.WS
$33.2B
$4.76K ﹤0.01%
111
DELL icon
358
Dell
DELL
$283B
$4.76K ﹤0.01%
29
BBH icon
359
VanEck Biotech ETF
BBH
$396M
$4.7K ﹤0.01%
25
SHEL icon
360
Shell
SHEL
$245B
$4.65K ﹤0.01%
50
JHX icon
361
James Hardie Industries
JHX
$15.4B
$4.64K ﹤0.01%
250
LCTX icon
362
Lineage Cell Therapeutics
LCTX
$257M
$4.62K ﹤0.01%
2,926
SCHR
363
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.2B
$4.48K ﹤0.01%
180
PFE icon
364
Pfizer
PFE
$140B
$4.32K ﹤0.01%
154
FTSL icon
365
First Trust Senior Loan Fund ETF
FTSL
$2.31B
$4.3K ﹤0.01%
96
SPMD icon
366
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.2B
$4.2K ﹤0.01%
+71
New +$4.32K
APH icon
367
Amphenol
APH
$188B
$4.17K ﹤0.01%
+33
New +$4.64K
NEWP
368
New Pacific Metals
NEWP
$833M
$4.14K ﹤0.01%
1,000
DRIV icon
369
Global X Autonomous & Electric Vehicles ETF
DRIV
$378M
$4K ﹤0.01%
131
SWK icon
370
Stanley Black & Decker
SWK
$14.2B
$3.84K ﹤0.01%
54
RF icon
371
Regions Financial
RF
$26.3B
$3.71K ﹤0.01%
142
SNDA icon
372
Sonida Senior Living
SNDA
$1.97B
$3.64K ﹤0.01%
+113
New +$3.78K
UBER icon
373
Uber
UBER
$134B
$3.6K ﹤0.01%
50
XEL icon
374
Xcel Energy
XEL
$51B
$3.58K ﹤0.01%
45
MRSH
375
Marsh
MRSH
$86.3B
$3.47K ﹤0.01%
20

Similar funds

Pacifica Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Pacifica Partners held 488 positions worth $301M, up 34% from $225M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Pacifica Partners deployed $69.8M of net new capital in Q1 2026, opening 53 new positions and adding to 41 existing holdings. Its largest new stake was Apple: 57,358 shares worth $14.6M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 15% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was SLB Ltd, an estimated $4.78M trimmed.

  • Pacifica Partners's largest Q1 2026 buy was Apple: 57,358 shares worth $14.6M.
  • Pacifica Partners added most to NVIDIA in Q1 2026, an estimated $2.06M increase.
  • Pacifica Partners's biggest Q1 2026 reduction was SLB Ltd, cutting an estimated $4.78M.
  • Pacifica Partners fully exited Colgate-Palmolive in Q1 2026, selling an estimated $678K.
  • Pacifica Partners's ten largest holdings make up 34% of its $301M portfolio in Q1 2026.
  • Pacifica Partners opened 53 new positions and closed 38 in Q1 2026.
  • Pacifica Partners's portfolio value rose 34% quarter-over-quarter to $301M.

Based on Pacifica Partners's 13F filing for Q1 2026, filed 9 Apr 2026.